Chapter 4: Cancer incidence in Canada: trends and projections (1983-2032) – Stomach cancer - HPCDP: Volume 35, Supplement 1, Spring 2015

Chapter 4: Projections by Cancer Site

3. Stomach cancer

Stomach cancer (sometimes referred to as gastric cancer) was responsible for approximately 1.9% of all incident cases of cancer in Canada in 2003–2007 (Tables 4.3.1 and 4.3.2). It is the tenth most common cancer in males and the fifteenth most common in females. One in 73 males and 1 in 127 females can expect to be diagnosed with stomach cancer in their lifetime, and 1 in 111 males and 1 in 195 females can expect to die from it.Endnote 1 On average, 1925 and 1080 new cases of stomach cancer were diagnosed each year in males and females, respectively, during 2003–2007.

TABLE 4.3.1
Observed (2003–2007) and projected average annual new cases by age and province/territories combined (TC), stomach cancer, males, Canada, 2003–2032
Period Age New cases
CA BC AB SK MB ON QC NB NS PE NL TC
2003–07 <45 75 10 10 0 5 30 15 0 0 0 0 0
45–54 200 25 20 5 10 70 50 5 10 0 5 0
55–64 400 50 30 10 15 145 105 10 15 0 15 0
65–74 545 70 45 15 20 205 145 15 15 0 15 0
75–84 535 65 40 15 25 190 150 15 15 0 15 0
85+ 175 25 15 5 10 55 45 5 5 0 5 0
Total 1925 245 160 55 80 700 510 55 65 5 50 5
2008–12 <45 70 10 10 0 0 30 15 0 0 0 0 0
45–54 205 25 20 5 10 85 45 5 10 0 5 0
55–64 440 55 35 10 20 160 110 15 15 0 15 0
65–74 560 70 45 15 20 205 150 15 20 5 15 0
75–84 550 75 45 15 20 195 155 15 15 0 10 0
85+ 200 30 20 5 10 70 50 5 5 0 5 0
Total 2020 260 170 55 80 745 525 55 65 10 50 5
2013–17 <45 70 10 10 0 0 30 15 0 0 0 0 0
45–54 200 30 15 5 5 80 40 5 5 0 0 0
55–64 460 55 40 15 25 175 105 10 15 0 10 0
65–74 650 80 55 15 25 245 165 20 20 5 20 0
75–84 545 75 45 15 20 200 155 15 15 0 10 0
85+ 225 35 20 5 10 80 60 5 5 0 5 0
Total 2150 280 185 55 85 805 540 60 70 10 50 5
2018–22 <45 65 10 10 0 0 30 15 0 0 0 0 0
45–54 195 30 15 0 5 80 40 5 5 0 0 0
55–64 480 60 40 15 20 195 105 10 15 0 10 0
65–74 735 100 65 20 35 270 175 20 25 5 20 0
75–84 585 75 50 15 20 215 160 15 20 5 15 0
85+ 250 35 20 5 10 95 65 5 10 0 5 0
Total 2315 310 200 55 95 880 560 60 70 10 50 5
2023–27 <45 65 10 5 0 0 25 10 0 0 0 0 0
45–54 195 30 10 0 5 85 45 5 5 0 0 0
55–64 480 70 35 10 20 190 95 10 15 0 5 0
65–74 790 105 75 25 35 300 180 20 25 5 20 0
75–84 705 95 60 15 30 260 190 25 20 5 15 0
85+ 255 35 25 5 10 100 65 5 10 0 5 0
Total 2490 340 215 60 100 960 585 60 75 10 50 5
2028–32 <45 55 10 5 0 0 25 10 0 0 0 0 0
45–54 185 25 10 0 5 80 40 5 5 0 0 0
55–64 475 70 30 10 15 185 95 5 10 0 5 0
65–74 845 110 75 20 35 340 185 20 25 5 15 5
75–84 820 120 75 20 40 295 210 25 25 5 20 0
85+ 300 40 30 5 10 115 75 10 10 0 5 0
Total 2680 370 225 60 110 1040 610 60 80 10 45 10

Abbreviations: AB, Alberta; BC, British Columbia; CA, Canada; MB, Manitoba; NB, New Brunswick; NL, Newfoundland and Labrador; NS, Nova Scotia; ON, Ontario; PE, Prince Edward Island; QC, Quebec; SK, Saskatchewan; TC, All Territories (Yukon, Northwest Territories and Nunavut).

Note: Totals may not add up due to rounding.

TABLE 4.3.2
Observed (2003–2007) and projected average annual new cases by age and province/territories combined (TC), stomach cancer, females, Canada, 2003–2032
Period Age New cases
CA BC AB SK MB ON QC NB NS PE NL TC
2003–07 <45 65 5 5 0 0 25 10 0 0 0 5 0
45–54 105 10 10 0 5 45 25 5 0 0 0 0
55–64 155 20 15 5 5 55 40 5 5 0 5 0
65–74 240 25 15 5 10 90 70 10 10 0 10 0
75–84 330 35 25 10 15 115 100 10 10 0 10 0
85+ 190 15 15 5 10 70 60 5 5 0 0 0
Total 1080 115 85 30 40 405 305 30 30 5 30 5
2008–12 <45 65 10 5 0 0 30 15 0 0 0 0 0
45–54 105 15 10 0 5 45 20 0 5 0 0 0
55–64 175 20 15 5 5 70 40 5 5 0 5 0
65–74 240 25 20 5 10 90 70 5 5 0 10 0
75–84 315 35 20 10 10 115 95 10 10 0 10 0
85+ 210 20 15 5 10 75 65 5 5 0 5 0
Total 1110 120 90 25 40 425 300 30 30 5 30 5
2013–17 <45 70 10 5 0 0 30 15 0 0 0 0 0
45–54 105 10 10 0 5 50 20 0 5 0 0 0
55–64 195 25 20 5 5 80 45 5 5 0 5 0
65–74 265 30 20 5 10 105 70 5 10 0 10 0
75–84 305 35 20 10 10 110 90 10 5 0 10 0
85+ 215 20 20 5 10 80 65 5 5 0 5 0
Total 1155 130 100 25 40 455 305 30 30 5 30 5
2018–22 <45 70 5 5 0 0 30 15 0 0 0 0 0
45–54 110 10 10 0 5 55 20 0 0 0 0 0
55–64 205 25 25 5 5 85 40 5 5 0 5 0
65–74 305 35 25 5 10 125 75 5 10 0 10 0
75–84 315 35 25 5 10 115 95 10 5 0 10 0
85+ 215 20 20 5 5 80 70 5 5 0 5 0
Total 1220 135 110 25 40 490 310 30 30 5 30 5
2023–27 <45 65 5 5 0 5 25 10 0 0 0 0 0
45–54 125 10 10 0 5 65 20 0 0 0 0 0
55–64 205 25 25 5 5 90 35 5 5 0 5 0
65–74 350 40 30 5 10 145 80 5 10 0 10 0
75–84 360 45 30 5 10 135 100 10 10 0 10 0
85+ 225 20 20 5 10 85 70 5 5 0 5 0
Total 1320 150 120 25 45 540 315 30 30 5 30 10
2028–32 <45 55 5 5 0 5 25 10 0 0 0 0 0
45–54 125 10 10 0 5 60 20 0 0 0 0 0
55–64 215 25 25 0 5 105 35 5 5 0 0 0
65–74 370 45 40 5 10 155 75 5 10 0 10 5
75–84 425 50 35 10 15 165 110 10 10 5 10 5
85+ 235 20 25 5 10 90 70 5 5 0 5 0
Total 1425 160 135 25 45 595 325 30 30 10 30 10

Abbreviations: AB, Alberta; BC, British Columbia; CA, Canada; MB, Manitoba; NB, New Brunswick; NL, Newfoundland and Labrador; NS, Nova Scotia; ON, Ontario; PE, Prince Edward Island; QC, Quebec; SK, Saskatchewan; TC, All Territories (Yukon, Northwest Territories and Nunavut).

Note: Totals may not add up due to rounding.

The overall incidence rate of stomach cancer in Canada has decreased for a long time (Figure 4.3.1). In 1998–2007, the incidence rate of stomach cancer was the second most rapidly decreasing of all cancers after larynx (2% per year in males and 1.6% per year in females) (Figures 3.1 and 3.2). Stomach cancer has a poor 5-year relative survival rate, at 23% in males and 28% in females in 2006–2008.Endnote 1

FIGURE 4.3.1
Age-standardized incidence rates (ASIRs) by region, stomach cancer, 1983–2032

Age-standardized incidence rates (ASIRs) by region, stomach cancer, 1983–2032

[Click to enlarge]

[FIGURE 4.3.1, Text Equivalent]

The overall incidence rate of stomach cancer in Canada has decreased. From 2003-2007 to 2028-2032, ASIRs of stomach cancer for Canada are expected to decrease by 30% in males, from 11.1 to 7.7 per 100 000, and by 24% in females, from 4.9 to 3.7 per 100 000. Elevated rates are reported for the Atlantic region, but the long-term trends indicate a convergence of rates in regions.

The incidence rates increased with age from 0.7 per 100 000 in males aged under 45 to 113.5 in those aged 85 or older, and from 0.6 to 55.1 per 100 000 in females for the same age groups (Tables 4.3.3 and 4.3.4) in 2003–2007. Most people diagnosed with stomach cancer are 65 or older (65% in men and 70% in women). The male-to-female ratio of rates approximated 1:1 in those younger than 45 and increased to 1.9:1 to 2.7:1 in the over-45-year age groups in 2003–2007.

TABLE 4.3.3
Observed (2003–2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), stomach cancer, males, Canada, 2003–2032
Period Age ASIRs
CA BC AB SK MB ON QC NB NS PE NL TC
2003–07 <45 0.7 0.6 0.8 0.4 0.8 0.7 0.7 0.6 0.7 0.4 0.9 0.6
45–54 7.9 7.5 8.2 6.1 10.7 7.6 7.9 7.5 10.7 13.3 9.9 7.6
55–64 23.6 20.9 21.2 19.3 27.7 23.4 24.2 26.3 26.9 12.6 42.2 25.6
65–74 50.7 44.6 47.1 50.4 50.0 50.2 54.2 61.1 47.3 42.9 73.3 84.7
75–84 86.1 74.1 80.2 64.7 93.7 79.5 103.1 107.1 91.4 50.4 148.1 61.3
85+ 113.5 103.4 103.6 82.5 116.8 101.6 138.8 126.3 137.9 106.3 223.3 290.3
Total 11.1 9.8 10.4 9.2 12.1 10.6 12.2 12.8 11.9 8.6 17.9 14.4
2008–12 <45 0.7 0.8 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.8 0.9
45–54 7.4 6.7 6.8 5.2 8.5 7.8 6.8 7.8 9.4 7.7 6.5 9.6
55–64 21.4 19.7 18.3 19.4 28.4 21.3 21.2 25.6 23.3 21.4 36.0 27.8
65–74 45.1 38.5 44.4 41.8 48.4 44.7 47.1 48.4 46.1 45.8 74.6 58.5
75–84 78.4 73.0 72.9 62.3 84.5 72.1 92.1 93.8 81.3 73.5 116.0 101.6
85+ 95.6 85.4 103.0 67.2 104.1 88.2 113.1 120.7 112.1 89.0 139.3 123.9
Total 10.0 9.0 9.41 8.4 11.2 9.7 10.7 11.3 10.7 9.7 15.1 12.9
2013–17 <45 0.7 0.7 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.5 0.8 0.9
45–54 7.4 8.1 5.2 4.1 8.0 7.3 6.2 7.2 7.9 7.1 5.4 9.6
55–64 19.6 17.6 17.4 19.3 28.0 19.6 19.0 19.4 23.6 19.9 28.6 25.4
65–74 41.6 35.8 38.6 38.2 48.5 41.7 42.1 49.7 41.7 42.3 73.4 53.9
75–84 70.6 64.5 68.5 57.8 76.5 66.8 81.2 81.5 71.3 68.0 88.7 91.5
85+ 84.1 78.9 87.9 55.4 90.8 77.8 98.5 103.1 98.5 82.3 138.7 109.0
Total 9.2 8.4 8.5 7.7 10.6 9.0 9.6 10.2 9.7 9.0 13.2 11.9
2018–22 <45 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.5 0.5 0.8 0.7
45–54 7.8 8.6 4.5 3.2 7.5 7.8 7.0 6.8 6.9 6.6 4.5 10.1
55–64 18.5 16.2 15.5 17.3 22.9 19.3 17.4 17.1 22.4 18.4 19.3 24.0
65–74 38.8 36.9 35.1 36.3 51.7 38.2 38.5 44.8 39.9 39.4 65.6 50.3
75–84 63.0 54.6 63.3 54.0 73.8 60.6 70.7 69.8 63.3 63.2 86.3 81.7
85+ 79.8 72.0 78.1 56.4 90.3 77.3 91.0 101.4 93.0 76.6 110.0 103.4
Total 8.5 7.9 7.7 7.2 10.3 8.5 8.7 9.2 9.0 8.4 11.4 11.1
2023–27 <45 0.6 0.5 0.5 0.6 0.6 0.6 0.4 0.6 0.5 0.5 0.8 0.7
45–54 7.5 7.8 3.8 2.5 7.0 8.3 7.6 6.4 6.0 6.2 3.7 9.8
55–64 18.5 19.3 12.6 14.5 21.8 18.4 16.3 15.2 19.5 17.3 16.8 24.0
65–74 36.1 33.1 34.0 36.1 50.0 36.1 35.2 36.2 40.7 37.0 52.0 46.8
75–84 58.8 52.4 55.9 49.6 73.3 57.2 64.5 72.5 57.9 59.3 82.3 76.3
85+ 69.8 62.6 77.3 49.4 76.8 68.7 78.4 80.5 78.6 72.0 82.9 90.4
Total 8.1 7.6 7.0 6.7 9.8 8.1 8.0 8.3 8.3 7.9 9.8 10.5
2028–32 <45 0.5 0.5 0.5 0.6 0.6 0.5 0.4 0.6 0.5 0.5 0.8 0.6
45–54 7.0 7.0 3.3 2.0 6.6 7.4 6.2 6.0 5.3 5.9 3.1 9.0
55–64 19.4 20.5 11.1 12.1 20.7 19.2 17.9 13.4 17.4 16.5 14.6 25.2
65–74 34.7 31.5 30.2 32.6 42.5 35.6 32.8 32.6 38.2 35.1 38.1 44.9
75–84 55.3 53.7 51.6 48.0 79.7 52.6 59.6 65.1 56.3 56.4 75.1 71.6
85+ 63.6 52.3 68.4 48.7 81.2 63.6 69.4 74.4 73.1 68.6 94.9 82.5
Total 7.7 7.5 6.3 6.1 9.5 7.8 7.5 7.5 7.8 7.5 8.4 10.0

Abbreviations: AB, Alberta; BC, British Columbia; CA, Canada; MB, Manitoba; NB, New Brunswick; NL, Newfoundland and Labrador; NS, Nova Scotia; ON, Ontario; PE, Prince Edward Island; QC, Quebec; SK, Saskatchewan; TC, All Territories (Yukon, Northwest Territories and Nunavut).

TABLE 4.3.4
Observed (2003–2007) and projected age-standardized incidence rates (ASIRs) by age and province/territories combined (TC), stomach cancer, females, Canada, 2003–2032
Period Age ASIRs
CA BC AB SK MB ON QC NB NS PE NL TC
2003–07 <45 0.6 0.5 0.7 0.6 0.6 0.7 0.5 0.8 0.5 1.5 1.6 2.8
45–54 4.1 3.7 3.9 3.0 3.7 4.7 3.9 4.8 2.4 1.7 4.4 2.8
55–64 8.7 8.0 10.0 6.4 9.4 8.6 8.7 7.5 8.6 4.8 15.2 23.1
65–74 20.2 15.2 15.3 18.7 18.7 19.7 22.8 26.4 20.6 44.0 42.5 27.5
75–84 37.5 31.3 35.1 30.4 35.6 34.2 45.8 42.8 32.0 32.4 76.1 92.7
85+ 55.1 35.8 54.7 35.7 47.4 54.3 74.4 62.9 47.9 21.4 47.0 96.5
Total 4.9 4.0 4.6 4.0 4.6 4.8 5.5 5.7 4.4 6.0 9.0 10.4
2008–12 <45 0.7 0.6 0.6 0.4 0.7 0.7 0.6 0.6 0.4 0.8 1.2 1.9
45–54 3.9 3.6 4.3 2.8 3.7 4.4 3.3 3.7 3.5 4.7 5.1 9.5
55–64 8.2 6.6 8.4 7.1 8.8 8.9 7.9 7.2 9.8 10.0 12.3 17.6
65–74 17.7 13.3 16.1 13.2 18.4 17.6 19.6 18.4 15.7 21.5 32.3 30.8
75–84 34.1 29.9 30.0 28.5 29.0 31.4 40.5 38.6 27.3 41.4 69.7 53.0
85+ 48.0 32.4 50.0 34.6 52.0 46.4 59.9 58.4 45.0 58.3 54.8 83.2
Total 4.5 3.7 4.3 3.5 4.4 4.5 4.8 4.7 4.0 5.5 7.7 8.7
2013–17 <45 0.7 0.6 0.4 0.4 0.7 0.8 0.6 0.6 0.4 0.8 1.2 2.0
45–54 3.9 3.4 4.5 2.5 3.7 4.5 3.1 3.7 3.5 4.7 4.4 10.1
55–64 8.1 7.0 8.4 6.2 7.6 8.6 7.4 6.4 7.8 9.9 12.3 19.2
65–74 15.6 12.1 15.5 11.0 16.5 16.2 16.5 15.9 13.7 19.0 25.8 34.4
75–84 31.2 26.4 27.1 25.8 29.9 28.8 37.0 34.0 25.1 37.9 60.1 59.6
85+ 42.6 29.2 42.7 29.7 39.9 42.3 52.5 51.9 37.4 51.8 54.5 92.9
Total 4.2 3.4 4.0 3.1 4.1 4.3 4.4 4.2 3.5 5.1 6.8 9.6
2018–22 <45 0.6 0.5 0.4 0.4 0.7 0.7 0.5 0.6 0.4 0.8 1.2 2.1
45–54 4.5 3.4 4.3 2.3 3.7 5.5 3.7 3.7 3.5 5.4 3.9 10.7
55–64 7.8 7.1 8.9 5.1 6.5 8.4 6.7 5.8 6.3 9.5 9.7 20.7
65–74 15.0 11.8 13.8 10.4 17.1 16.3 14.9 13.7 14.2 18.3 25.7 37.9
75–84 27.7 22.8 26.6 21.7 27.2 25.9 32.6 29.9 19.6 33.7 47.6 66.8
85+ 38.1 26.4 37.5 25.6 34.4 36.7 47.8 46.2 32.2 46.4 52.5 104.0
Total 4.0 3.2 3.8 2.7 3.9 4.2 4.0 3.8 3.2 4.9 6.1 10.4
2023–27 <45 0.5 0.5 0.4 0.4 0.7 0.6 0.5 0.6 0.4 0.7 1.2 2.2
45–54 4.9 3.0 3.3 2.1 3.7 6.1 4.0 3.7 3.5 5.9 3.4 11.2
55–64 7.8 6.8 9.2 4.2 5.6 8.6 6.2 5.2 5.0 9.5 7.6 22.1
65–74 14.9 12.6 14.1 9.2 15.2 16.0 14.3 11.8 11.8 18.1 25.1 41.2
75–84 25.0 21.4 25.5 19.1 26.1 24.4 28.1 26.4 19.1 30.4 39.2 74.4
85+ 35.9 23.1 35.0 24.4 40.7 35.4 44.5 41.2 31.7 43.7 41.0 116.6
Total 3.9 3.1 3.6 2.4 3.7 4.1 3.7 3.5 2.9 4.7 5.4 11.3
2028–32 <45 0.5 0.4 0.3 0.4 0.7 0.5 0.4 0.6 0.4 0.6 1.2 2.3
45–54 4.6 2.6 2.9 1.9 3.7 5.4 3.5 3.7 3.5 5.6 3.1 11.7
55–64 8.8 6.9 9.0 3.4 4.8 10.2 7.3 4.8 4.0 10.7 5.9 23.3
65–74 14.4 12.7 14.7 7.7 13.4 15.7 13.0 10.2 9.7 17.5 20.5 44.4
75–84 24.4 20.9 22.8 18.2 26.3 24.7 25.9 23.2 18.8 29.6 39.6 81.9
85+ 30.8 19.7 35.8 18.6 30.4 30.6 38.0 36.7 21.3 37.5 32.4 130.8
Total 3.7 3.0 3.5 2.2 3.4 4.1 3.5 3.1 2.5 4.6 4.8 12.1

Abbreviations: AB, Alberta; BC, British Columbia; CA, Canada; MB, Manitoba; NB, New Brunswick; NL, Newfoundland and Labrador; NS, Nova Scotia; ON, Ontario; PE, Prince Edward Island; QC, Quebec; SK, Saskatchewan; TC, All Territories (Yukon, Northwest Territories and Nunavut).

From 2003–2007 to 2028–2032, ASIRs of stomach cancer for Canada are expected to decrease by 30% in males, from 11.1 to 7.7 per 100 000, and by 24% in females, from 4.9 to 3.7 per 100 000 (Tables 4.3.3 and 4.3.4). With the projected Canada population growth and aging, however, the annual number of male cases is predicted to rise by 39%, from 1925 to 2680, and the number of female cases is predicted to rise by 32%, from 1080 to 1425 (Tables 4.3.1 and 4.3.2). The projected long-term trends in males and females show a tendency toward a convergence of rates in each age group (Figure 4.3.2). Elevated rates are reported for the Atlantic region, with the highest rates in Newfoundland and Labrador, but the long-term trends indicate a convergence of rates in regions as well (Figure 4.3.1).

FIGURE 4.3.2
Age-standardized incidence rates (ASIRs) for stomach cancer by age group, Canada, 1983–2032 (red lines denote males, blue lines denote females)

figure 4.3.2

[Click to enlarge]

[FIGURE 4.3.2, Text Equivalent]

The overall incidence rate of stomach cancer in Canada will continue to decrease in males in each age group and in females aged 55 and over. The projected long-term trends in males and females show a tendency toward a convergence of rates in each age group.

Comments

The gram-negative bacterium Helicobacter pylori (H. pylori) is a major risk factor for stomach cancer. In addition, dietary habits, tobacco smoking, alcohol, genetic factors, occupational exposure to dusty and high temperature environments, Xradiation, gamma-radiation and socioeconomic factors contribute to stomach carcinogenesis. Endnote 47, Endnote 79

Elevated risk for stomach cancer has been linked to diets rich in starch, poor in protein quality, and poor in fruits and vegetables.Endnote 79 A meta-analysis of prospective studies found that stomach cancer risk increases with increasing salt intake.Endnote 80 High salt intake may cause damage to gastric mucosa and help H. pylori colonization. Endnote 79 Dietary nitrate can also increase stomach cancer risk, as it may result in endogenous N-nitrosation.

Since the early 1960s, annual per capita fruit and vegetable consumption rates in Canada have increased by over 30%, from 84 kg of fruits and 139 kg of vegetables in 1963 to 132 kg of fruits and 179 kg of vegetables in 2009.Endnote 81 The decrease in stomach cancer incidence rates may be attributable to improved healthy lifestyles such as decreased smokingEndnote 42, Endnote 43 and changes in diet,Endnote 82 and more recently to the increased recognition and treatment of H. pylori infection.Endnote 83

Page details

Date modified: